Yoshida O - Search Results

1

Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).

Al Mahtab M, Akbar SMF, Aguilar JC, Guillen G, Penton E, Tuero A, Yoshida O, Hiasa Y, Onji M. Al Mahtab M, et al. Among authors: yoshida o. PLoS One. 2018 Aug 22;13(8):e0201236. doi: 10.1371/journal.pone.0201236. eCollection 2018. PLoS One. 2018. PMID: 30133478 Free PMC article. Clinical Trial.

2

Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection.

Akbar SM, Yoshida O, Chen S, Cesar AJ, Abe M, Matsuura B, Hiasa Y, Onji M. Akbar SM, et al. Among authors: yoshida o. Antivir Ther. 2010;15(6):887-95. doi: 10.3851/IMP1637. Antivir Ther. 2010. PMID: 20834101

3

Novel insights into immunotherapy for hepatitis B patients.

Akbar SM, Al-Mahtab M, Jahan M, Yoshida O, Hiasa Y. Akbar SM, et al. Among authors: yoshida o. Expert Rev Gastroenterol Hepatol. 2016;10(2):267-76. doi: 10.1586/17474124.2016.1112266. Epub 2015 Dec 2. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26626120 Review.

4

Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial.

Akbar SMF, Al Mahtab M, Aguilar JC, Yoshida O, Penton E, Gerardo GN, Hiasa Y. Akbar SMF, et al. Among authors: yoshida o. Pathogens. 2021 Nov 5;10(11):1440. doi: 10.3390/pathogens10111440. Pathogens. 2021. PMID: 34832596 Free PMC article.

5

The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial.

Akbar SMF, Al Mahtab M, Aguilar JC, Yoshida O, Khan S, Penton E, Gerardo GN, Hiasa Y. Akbar SMF, et al. Among authors: yoshida o. Vaccines (Basel). 2021 Dec 30;10(1):45. doi: 10.3390/vaccines10010045. Vaccines (Basel). 2021. PMID: 35062707 Free PMC article.

6

Immune therapies against chronic hepatitis B.

Akbar SMF, Yoshida O, Hiasa Y. Akbar SMF, et al. Among authors: yoshida o. J Gastroenterol. 2022 Aug;57(8):517-528. doi: 10.1007/s00535-022-01890-8. Epub 2022 Jun 16. J Gastroenterol. 2022. PMID: 35708793 Free PMC article. Review.

7

Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice.

Niiya T, Akbar SM, Yoshida O, Miyake T, Matsuura B, Murakami H, Abe M, Hiasa Y, Onji M. Niiya T, et al. Among authors: yoshida o. J Nutr. 2007 Mar;137(3):671-5. doi: 10.1093/jn/137.3.671. J Nutr. 2007. PMID: 17311958 Free article.

8

Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells.

Fazle Akbar SM, Furukawa S, Yoshida O, Hiasa Y, Horiike N, Onji M. Fazle Akbar SM, et al. Among authors: yoshida o. J Hepatol. 2007 Jul;47(1):60-6. doi: 10.1016/j.jhep.2007.02.021. Epub 2007 Apr 9. J Hepatol. 2007. PMID: 17467112 Clinical Trial.

9

Engineering immune therapy against hepatitis B virus.

Akbar F, Yoshida O, Abe M, Hiasa Y, Onji M. Akbar F, et al. Among authors: yoshida o. Hepatol Res. 2007 Oct;37 Suppl 3:S351-6. doi: 10.1111/j.1872-034X.2007.00251.x. Hepatol Res. 2007. PMID: 17931186

10

Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease.

Miyake T, Akbar SM, Yoshida O, Chen S, Hiasa Y, Matsuura B, Abe M, Onji M. Miyake T, et al. Among authors: yoshida o. J Gastroenterol. 2010 Aug;45(8):859-67. doi: 10.1007/s00535-010-0218-4. Epub 2010 Mar 2. J Gastroenterol. 2010. PMID: 20195647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

947 results

Search Page